nodes	percent_of_prediction	percent_of_DWPC	metapath
Theophylline—CYP2C9—brain cancer	0.369	1	CbGaD
Theophylline—CYP1B1—Procarbazine—brain cancer	0.23	0.571	CbGbCtD
Theophylline—CYP2D6—Lomustine—brain cancer	0.0316	0.0785	CbGbCtD
Theophylline—CYP1A2—Carmustine—brain cancer	0.0313	0.0776	CbGbCtD
Theophylline—CYP2D6—Hydroxyurea—brain cancer	0.0239	0.0595	CbGbCtD
Theophylline—CYP3A4—Temozolomide—brain cancer	0.0236	0.0587	CbGbCtD
Theophylline—CYP3A4—Lomustine—brain cancer	0.0201	0.0499	CbGbCtD
Theophylline—CYP2E1—Etoposide—brain cancer	0.016	0.0398	CbGbCtD
Theophylline—CYP2C8—Etoposide—brain cancer	0.012	0.0297	CbGbCtD
Theophylline—CYP1A2—Etoposide—brain cancer	0.00927	0.023	CbGbCtD
Theophylline—CYP3A4—Etoposide—brain cancer	0.00485	0.0121	CbGbCtD
Theophylline—Venous thrombosis—Carboplatin—brain cancer	0.00379	0.0515	CcSEcCtD
Theophylline—Fluid overload—Carboplatin—brain cancer	0.00329	0.0447	CcSEcCtD
Theophylline—Intoxication—Hydroxyurea—brain cancer	0.00326	0.0444	CcSEcCtD
Theophylline—Poisoning—Hydroxyurea—brain cancer	0.00326	0.0444	CcSEcCtD
Theophylline—Status epilepticus—Temozolomide—brain cancer	0.00291	0.0396	CcSEcCtD
Theophylline—PDE4C—ganglion—brain cancer	0.0027	0.0466	CbGeAlD
Theophylline—HDAC2—telencephalic ventricle—brain cancer	0.00269	0.0465	CbGeAlD
Theophylline—Extravasation—Carboplatin—brain cancer	0.00234	0.0319	CcSEcCtD
Theophylline—Gastric irritation—Hydroxyurea—brain cancer	0.00227	0.0308	CcSEcCtD
Theophylline—ADORA2A—ganglion—brain cancer	0.00196	0.0339	CbGeAlD
Theophylline—HDAC2—Teniposide—Etoposide—brain cancer	0.00176	1	CbGdCrCtD
Theophylline—Phlebitis—Carboplatin—brain cancer	0.00172	0.0234	CcSEcCtD
Theophylline—ADORA1—ganglion—brain cancer	0.00169	0.0293	CbGeAlD
Theophylline—Epigastric discomfort—Hydroxyurea—brain cancer	0.00167	0.0227	CcSEcCtD
Theophylline—Haematemesis—Procarbazine—brain cancer	0.00164	0.0222	CcSEcCtD
Theophylline—PDE5A—endothelium—brain cancer	0.00154	0.0266	CbGeAlD
Theophylline—Disorientation—Lomustine—brain cancer	0.00145	0.0197	CcSEcCtD
Theophylline—PDE5A—blood vessel—brain cancer	0.00142	0.0246	CbGeAlD
Theophylline—HDAC2—hindbrain—brain cancer	0.00127	0.0219	CbGeAlD
Theophylline—PDE4C—brainstem—brain cancer	0.00117	0.0203	CbGeAlD
Theophylline—PDE4C—telencephalon—brain cancer	0.00104	0.018	CbGeAlD
Theophylline—Coma—Procarbazine—brain cancer	0.00104	0.0141	CcSEcCtD
Theophylline—Hyperuricaemia—Hydroxyurea—brain cancer	0.000948	0.0129	CcSEcCtD
Theophylline—Disorientation—Procarbazine—brain cancer	0.000922	0.0125	CcSEcCtD
Theophylline—PDE4D—telencephalon—brain cancer	0.000916	0.0158	CbGeAlD
Theophylline—Blood uric acid increased—Hydroxyurea—brain cancer	0.000895	0.0122	CcSEcCtD
Theophylline—PDE3B—pituitary gland—brain cancer	0.000894	0.0155	CbGeAlD
Theophylline—Extravasation—Carmustine—brain cancer	0.000815	0.0111	CcSEcCtD
Theophylline—PDE4A—telencephalon—brain cancer	0.00081	0.014	CbGeAlD
Theophylline—Alopecia—Lomustine—brain cancer	0.000794	0.0108	CcSEcCtD
Theophylline—ADORA2A—telencephalon—brain cancer	0.000757	0.0131	CbGeAlD
Theophylline—PDE4C—midbrain—brain cancer	0.000747	0.0129	CbGeAlD
Theophylline—ADORA2B—pituitary gland—brain cancer	0.00074	0.0128	CbGeAlD
Theophylline—HDAC2—brainstem—brain cancer	0.000727	0.0126	CbGeAlD
Theophylline—Infection—Carboplatin—brain cancer	0.000725	0.00986	CcSEcCtD
Theophylline—Disorientation—Hydroxyurea—brain cancer	0.000713	0.0097	CcSEcCtD
Theophylline—PDE3B—endocrine gland—brain cancer	0.000692	0.012	CbGeAlD
Theophylline—PDE5A—telencephalon—brain cancer	0.000689	0.0119	CbGeAlD
Theophylline—ADORA1—telencephalon—brain cancer	0.000653	0.0113	CbGeAlD
Theophylline—Coma—Carmustine—brain cancer	0.000649	0.00883	CcSEcCtD
Theophylline—PDE4C—head—brain cancer	0.000648	0.0112	CbGeAlD
Theophylline—HDAC2—telencephalon—brain cancer	0.000645	0.0112	CbGeAlD
Theophylline—Infection—Lomustine—brain cancer	0.000634	0.00863	CcSEcCtD
Theophylline—ADORA2A—gonad—brain cancer	0.000631	0.0109	CbGeAlD
Theophylline—Extravasation—Etoposide—brain cancer	0.00063	0.00857	CcSEcCtD
Theophylline—PDE3B—cerebellum—brain cancer	0.00061	0.0105	CbGeAlD
Theophylline—Anorexia—Lomustine—brain cancer	0.000609	0.00828	CcSEcCtD
Theophylline—Haematuria—Procarbazine—brain cancer	0.000606	0.00824	CcSEcCtD
Theophylline—Phlebitis—Carmustine—brain cancer	0.000599	0.00814	CcSEcCtD
Theophylline—Hyperuricaemia—Etoposide—brain cancer	0.000592	0.00806	CcSEcCtD
Theophylline—PDE4C—central nervous system—brain cancer	0.000591	0.0102	CbGeAlD
Theophylline—Body temperature increased—Carboplatin—brain cancer	0.000577	0.00785	CcSEcCtD
Theophylline—PDE5A—gonad—brain cancer	0.000575	0.00995	CbGeAlD
Theophylline—ADORA2B—head—brain cancer	0.000566	0.00979	CbGeAlD
Theophylline—Blood uric acid increased—Etoposide—brain cancer	0.00056	0.00761	CcSEcCtD
Theophylline—Decreased appetite—Lomustine—brain cancer	0.000555	0.00755	CcSEcCtD
Theophylline—HDAC2—gonad—brain cancer	0.000539	0.00931	CbGeAlD
Theophylline—ADORA2A—spinal cord—brain cancer	0.00053	0.00917	CbGeAlD
Theophylline—Flushing—Procarbazine—brain cancer	0.000529	0.0072	CcSEcCtD
Theophylline—Dermatitis exfoliative—Temozolomide—brain cancer	0.000528	0.00719	CcSEcCtD
Theophylline—HDAC2—pituitary gland—brain cancer	0.000525	0.00909	CbGeAlD
Theophylline—ADA—endocrine gland—brain cancer	0.000525	0.00907	CbGeAlD
Theophylline—ADA—head—brain cancer	0.000518	0.00896	CbGeAlD
Theophylline—ADORA2B—central nervous system—brain cancer	0.000517	0.00894	CbGeAlD
Theophylline—ADORA1—medulla oblongata—brain cancer	0.000513	0.00888	CbGeAlD
Theophylline—Arrhythmia—Procarbazine—brain cancer	0.00051	0.00693	CcSEcCtD
Theophylline—PDE4D—cerebellum—brain cancer	0.000509	0.0088	CbGeAlD
Theophylline—HDAC2—medulla oblongata—brain cancer	0.000507	0.00877	CbGeAlD
Theophylline—ADORA2B—cerebellum—brain cancer	0.000505	0.00874	CbGeAlD
Theophylline—Body temperature increased—Lomustine—brain cancer	0.000505	0.00686	CcSEcCtD
Theophylline—Alopecia—Procarbazine—brain cancer	0.000504	0.00686	CcSEcCtD
Theophylline—PDE3B—brain—brain cancer	0.000495	0.00856	CbGeAlD
Theophylline—Tension—Procarbazine—brain cancer	0.000487	0.00663	CcSEcCtD
Theophylline—PDE4B—telencephalon—brain cancer	0.000483	0.00836	CbGeAlD
Theophylline—Nervousness—Procarbazine—brain cancer	0.000482	0.00656	CcSEcCtD
Theophylline—ADORA2A—endocrine gland—brain cancer	0.000477	0.00825	CbGeAlD
Theophylline—SLC22A7—endocrine gland—brain cancer	0.000473	0.00818	CbGeAlD
Theophylline—ADA—central nervous system—brain cancer	0.000473	0.00818	CbGeAlD
Theophylline—ADORA2A—head—brain cancer	0.000471	0.00815	CbGeAlD
Theophylline—Hypokalaemia—Carmustine—brain cancer	0.00047	0.00639	CcSEcCtD
Theophylline—PDE4C—brain—brain cancer	0.000469	0.00812	CbGeAlD
Theophylline—ADORA1—midbrain—brain cancer	0.000469	0.00811	CbGeAlD
Theophylline—Tremor—Procarbazine—brain cancer	0.000465	0.00633	CcSEcCtD
Theophylline—HDAC2—midbrain—brain cancer	0.000463	0.00801	CbGeAlD
Theophylline—Phlebitis—Etoposide—brain cancer	0.000463	0.0063	CcSEcCtD
Theophylline—ADORA1—spinal cord—brain cancer	0.000458	0.00792	CbGeAlD
Theophylline—Hypokalaemia—Temozolomide—brain cancer	0.000454	0.00617	CcSEcCtD
Theophylline—PDE4A—cerebellum—brain cancer	0.00045	0.00779	CbGeAlD
Theophylline—PDE5A—endocrine gland—brain cancer	0.000435	0.00752	CbGeAlD
Theophylline—Convulsion—Procarbazine—brain cancer	0.00043	0.00585	CcSEcCtD
Theophylline—ADORA2A—central nervous system—brain cancer	0.00043	0.00744	CbGeAlD
Theophylline—PDE5A—head—brain cancer	0.000429	0.00742	CbGeAlD
Theophylline—PDE3A—endocrine gland—brain cancer	0.000423	0.00731	CbGeAlD
Theophylline—Anxiety—Procarbazine—brain cancer	0.000421	0.00573	CcSEcCtD
Theophylline—ADORA2A—cerebellum—brain cancer	0.00042	0.00727	CbGeAlD
Theophylline—Caffeine—CYP2C9—brain cancer	0.000417	1	CrCbGaD
Theophylline—CYP2D6—hindbrain—brain cancer	0.000416	0.00719	CbGeAlD
Theophylline—CYP1B1—telencephalon—brain cancer	0.000414	0.00716	CbGeAlD
Theophylline—PDE4D—brain—brain cancer	0.000413	0.00715	CbGeAlD
Theophylline—Anaphylactoid reaction—Etoposide—brain cancer	0.000412	0.00561	CcSEcCtD
Theophylline—ADORA1—endocrine gland—brain cancer	0.000412	0.00713	CbGeAlD
Theophylline—ADORA2B—brain—brain cancer	0.00041	0.0071	CbGeAlD
Theophylline—HDAC2—endocrine gland—brain cancer	0.000407	0.00704	CbGeAlD
Theophylline—ADORA1—head—brain cancer	0.000407	0.00704	CbGeAlD
Theophylline—Vomiting—Lomustine—brain cancer	0.000406	0.00552	CcSEcCtD
Theophylline—PDE4B—gonad—brain cancer	0.000403	0.00697	CbGeAlD
Theophylline—Infection—Procarbazine—brain cancer	0.000403	0.00548	CcSEcCtD
Theophylline—Hyperglycaemia—Carmustine—brain cancer	0.000402	0.00547	CcSEcCtD
Theophylline—HDAC2—head—brain cancer	0.000402	0.00695	CbGeAlD
Theophylline—Shock—Procarbazine—brain cancer	0.000399	0.00542	CcSEcCtD
Theophylline—Tachycardia—Procarbazine—brain cancer	0.000396	0.00538	CcSEcCtD
Theophylline—PDE4B—pituitary gland—brain cancer	0.000393	0.0068	CbGeAlD
Theophylline—PDE5A—central nervous system—brain cancer	0.000392	0.00677	CbGeAlD
Theophylline—Alopecia—Hydroxyurea—brain cancer	0.00039	0.00531	CcSEcCtD
Theophylline—Hyperglycaemia—Temozolomide—brain cancer	0.000389	0.00529	CcSEcCtD
Theophylline—Anorexia—Procarbazine—brain cancer	0.000386	0.00525	CcSEcCtD
Theophylline—PDE5A—cerebellum—brain cancer	0.000383	0.00662	CbGeAlD
Theophylline—PDE4B—medulla oblongata—brain cancer	0.00038	0.00657	CbGeAlD
Theophylline—Nausea—Lomustine—brain cancer	0.000379	0.00516	CcSEcCtD
Theophylline—Hypotension—Procarbazine—brain cancer	0.000379	0.00515	CcSEcCtD
Theophylline—ADA—brain—brain cancer	0.000375	0.00649	CbGeAlD
Theophylline—PDE3A—cerebellum—brain cancer	0.000372	0.00644	CbGeAlD
Theophylline—ADORA1—central nervous system—brain cancer	0.000371	0.00642	CbGeAlD
Theophylline—HDAC2—central nervous system—brain cancer	0.000367	0.00634	CbGeAlD
Theophylline—Insomnia—Procarbazine—brain cancer	0.000367	0.00499	CcSEcCtD
Theophylline—PDE4A—brain—brain cancer	0.000366	0.00632	CbGeAlD
Theophylline—ADORA1—cerebellum—brain cancer	0.000363	0.00628	CbGeAlD
Theophylline—HDAC2—cerebellum—brain cancer	0.000359	0.0062	CbGeAlD
Theophylline—Decreased appetite—Procarbazine—brain cancer	0.000352	0.00479	CcSEcCtD
Theophylline—PDE4B—midbrain—brain cancer	0.000347	0.006	CbGeAlD
Theophylline—CYP1B1—gonad—brain cancer	0.000346	0.00598	CbGeAlD
Theophylline—ADORA2A—brain—brain cancer	0.000341	0.0059	CbGeAlD
Theophylline—PDE4B—spinal cord—brain cancer	0.000339	0.00586	CbGeAlD
Theophylline—SLC22A7—brain—brain cancer	0.000338	0.00585	CbGeAlD
Theophylline—CYP1B1—pituitary gland—brain cancer	0.000337	0.00583	CbGeAlD
Theophylline—Convulsion—Hydroxyurea—brain cancer	0.000333	0.00453	CcSEcCtD
Theophylline—Gastrointestinal pain—Procarbazine—brain cancer	0.000331	0.00451	CcSEcCtD
Theophylline—Flushing—Carmustine—brain cancer	0.000331	0.0045	CcSEcCtD
Theophylline—Urticaria—Procarbazine—brain cancer	0.000322	0.00438	CcSEcCtD
Theophylline—Abdominal pain—Procarbazine—brain cancer	0.00032	0.00436	CcSEcCtD
Theophylline—Body temperature increased—Procarbazine—brain cancer	0.00032	0.00436	CcSEcCtD
Theophylline—Flushing—Temozolomide—brain cancer	0.00032	0.00435	CcSEcCtD
Theophylline—Arrhythmia—Carmustine—brain cancer	0.000319	0.00434	CcSEcCtD
Theophylline—Alopecia—Carmustine—brain cancer	0.000315	0.00429	CcSEcCtD
Theophylline—Infection—Hydroxyurea—brain cancer	0.000312	0.00424	CcSEcCtD
Theophylline—PDE5A—brain—brain cancer	0.000311	0.00538	CbGeAlD
Theophylline—Nervous system disorder—Hydroxyurea—brain cancer	0.000308	0.00418	CcSEcCtD
Theophylline—PDE4B—endocrine gland—brain cancer	0.000305	0.00527	CbGeAlD
Theophylline—Alopecia—Temozolomide—brain cancer	0.000305	0.00415	CcSEcCtD
Theophylline—PDE3A—brain—brain cancer	0.000303	0.00523	CbGeAlD
Theophylline—PDE4B—head—brain cancer	0.000301	0.0052	CbGeAlD
Theophylline—Anorexia—Hydroxyurea—brain cancer	0.000299	0.00407	CcSEcCtD
Theophylline—Hypersensitivity—Procarbazine—brain cancer	0.000299	0.00406	CcSEcCtD
Theophylline—ADORA1—brain—brain cancer	0.000295	0.0051	CbGeAlD
Theophylline—HDAC2—brain—brain cancer	0.000291	0.00504	CbGeAlD
Theophylline—Tremor—Carmustine—brain cancer	0.000291	0.00396	CcSEcCtD
Theophylline—Pruritus—Procarbazine—brain cancer	0.000287	0.0039	CcSEcCtD
Theophylline—Agitation—Carmustine—brain cancer	0.000286	0.00388	CcSEcCtD
Theophylline—Tremor—Temozolomide—brain cancer	0.000281	0.00383	CcSEcCtD
Theophylline—Diarrhoea—Procarbazine—brain cancer	0.000277	0.00377	CcSEcCtD
Theophylline—Agitation—Temozolomide—brain cancer	0.000276	0.00375	CcSEcCtD
Theophylline—PDE4B—central nervous system—brain cancer	0.000275	0.00475	CbGeAlD
Theophylline—Decreased appetite—Hydroxyurea—brain cancer	0.000273	0.00371	CcSEcCtD
Theophylline—Convulsion—Carmustine—brain cancer	0.000269	0.00366	CcSEcCtD
Theophylline—PDE4B—cerebellum—brain cancer	0.000268	0.00464	CbGeAlD
Theophylline—Dizziness—Procarbazine—brain cancer	0.000268	0.00365	CcSEcCtD
Theophylline—CYP2E1—telencephalon—brain cancer	0.000267	0.00462	CbGeAlD
Theophylline—Palpitations—Temozolomide—brain cancer	0.000265	0.00361	CcSEcCtD
Theophylline—Anxiety—Carmustine—brain cancer	0.000264	0.00359	CcSEcCtD
Theophylline—CYP1B1—endocrine gland—brain cancer	0.000261	0.00452	CbGeAlD
Theophylline—Convulsion—Temozolomide—brain cancer	0.00026	0.00354	CcSEcCtD
Theophylline—CYP2C8—pituitary gland—brain cancer	0.000258	0.00447	CbGeAlD
Theophylline—CYP1B1—head—brain cancer	0.000258	0.00446	CbGeAlD
Theophylline—Vomiting—Procarbazine—brain cancer	0.000258	0.0035	CcSEcCtD
Theophylline—Flushing—Etoposide—brain cancer	0.000256	0.00348	CcSEcCtD
Theophylline—Rash—Procarbazine—brain cancer	0.000256	0.00348	CcSEcCtD
Theophylline—Dermatitis—Procarbazine—brain cancer	0.000255	0.00347	CcSEcCtD
Theophylline—Anxiety—Temozolomide—brain cancer	0.000255	0.00346	CcSEcCtD
Theophylline—Headache—Procarbazine—brain cancer	0.000254	0.00345	CcSEcCtD
Theophylline—Infection—Carmustine—brain cancer	0.000252	0.00343	CcSEcCtD
Theophylline—Body temperature increased—Hydroxyurea—brain cancer	0.000248	0.00337	CcSEcCtD
Theophylline—Tachycardia—Carmustine—brain cancer	0.000247	0.00337	CcSEcCtD
Theophylline—Anaphylactic shock—Temozolomide—brain cancer	0.000245	0.00333	CcSEcCtD
Theophylline—Alopecia—Etoposide—brain cancer	0.000244	0.00332	CcSEcCtD
Theophylline—Infection—Temozolomide—brain cancer	0.000243	0.00331	CcSEcCtD
Theophylline—Anorexia—Carmustine—brain cancer	0.000242	0.00329	CcSEcCtD
Theophylline—Nausea—Procarbazine—brain cancer	0.000241	0.00327	CcSEcCtD
Theophylline—Nervous system disorder—Temozolomide—brain cancer	0.00024	0.00327	CcSEcCtD
Theophylline—CYP2D6—brainstem—brain cancer	0.000238	0.00412	CbGeAlD
Theophylline—Hypotension—Carmustine—brain cancer	0.000237	0.00322	CcSEcCtD
Theophylline—CYP1B1—central nervous system—brain cancer	0.000235	0.00407	CbGeAlD
Theophylline—Anorexia—Temozolomide—brain cancer	0.000234	0.00318	CcSEcCtD
Theophylline—Hypersensitivity—Hydroxyurea—brain cancer	0.000231	0.00314	CcSEcCtD
Theophylline—CYP1B1—cerebellum—brain cancer	0.00023	0.00398	CbGeAlD
Theophylline—Insomnia—Carmustine—brain cancer	0.000229	0.00312	CcSEcCtD
Theophylline—Insomnia—Temozolomide—brain cancer	0.000222	0.00301	CcSEcCtD
Theophylline—Decreased appetite—Carmustine—brain cancer	0.00022	0.003	CcSEcCtD
Theophylline—PDE4B—brain—brain cancer	0.000218	0.00377	CbGeAlD
Theophylline—Diarrhoea—Hydroxyurea—brain cancer	0.000215	0.00292	CcSEcCtD
Theophylline—Decreased appetite—Temozolomide—brain cancer	0.000213	0.0029	CcSEcCtD
Theophylline—CYP2D6—telencephalon—brain cancer	0.000211	0.00366	CbGeAlD
Theophylline—CYP2E1—medulla oblongata—brain cancer	0.00021	0.00363	CbGeAlD
Theophylline—Convulsion—Etoposide—brain cancer	0.000208	0.00283	CcSEcCtD
Theophylline—Dizziness—Hydroxyurea—brain cancer	0.000207	0.00282	CcSEcCtD
Theophylline—Gastrointestinal pain—Carmustine—brain cancer	0.000207	0.00282	CcSEcCtD
Theophylline—Abdominal pain—Carmustine—brain cancer	0.0002	0.00273	CcSEcCtD
Theophylline—Body temperature increased—Carmustine—brain cancer	0.0002	0.00273	CcSEcCtD
Theophylline—Gastrointestinal pain—Temozolomide—brain cancer	0.0002	0.00273	CcSEcCtD
Theophylline—CYP2C8—endocrine gland—brain cancer	0.0002	0.00346	CbGeAlD
Theophylline—Vomiting—Hydroxyurea—brain cancer	0.000199	0.00271	CcSEcCtD
Theophylline—Rash—Hydroxyurea—brain cancer	0.000198	0.00269	CcSEcCtD
Theophylline—Dermatitis—Hydroxyurea—brain cancer	0.000198	0.00269	CcSEcCtD
Theophylline—Headache—Hydroxyurea—brain cancer	0.000197	0.00267	CcSEcCtD
Theophylline—Anaphylactic shock—Etoposide—brain cancer	0.000196	0.00267	CcSEcCtD
Theophylline—Infection—Etoposide—brain cancer	0.000195	0.00265	CcSEcCtD
Theophylline—Urticaria—Temozolomide—brain cancer	0.000195	0.00265	CcSEcCtD
Theophylline—Abdominal pain—Temozolomide—brain cancer	0.000194	0.00263	CcSEcCtD
Theophylline—Body temperature increased—Temozolomide—brain cancer	0.000194	0.00263	CcSEcCtD
Theophylline—Tachycardia—Etoposide—brain cancer	0.000191	0.0026	CcSEcCtD
Theophylline—CYP1A2—endocrine gland—brain cancer	0.000187	0.00324	CbGeAlD
Theophylline—CYP2E1—spinal cord—brain cancer	0.000187	0.00324	CbGeAlD
Theophylline—Anorexia—Etoposide—brain cancer	0.000187	0.00254	CcSEcCtD
Theophylline—CYP1B1—brain—brain cancer	0.000187	0.00323	CbGeAlD
Theophylline—Hypersensitivity—Carmustine—brain cancer	0.000187	0.00254	CcSEcCtD
Theophylline—Nausea—Hydroxyurea—brain cancer	0.000186	0.00253	CcSEcCtD
Theophylline—CYP1A1—endocrine gland—brain cancer	0.000185	0.00319	CbGeAlD
Theophylline—Hypotension—Etoposide—brain cancer	0.000183	0.00249	CcSEcCtD
Theophylline—CYP1A1—head—brain cancer	0.000182	0.00315	CbGeAlD
Theophylline—Hypersensitivity—Temozolomide—brain cancer	0.000181	0.00246	CcSEcCtD
Theophylline—CYP2C9—endocrine gland—brain cancer	0.000178	0.00307	CbGeAlD
Theophylline—Diarrhoea—Carmustine—brain cancer	0.000173	0.00236	CcSEcCtD
Theophylline—Pruritus—Temozolomide—brain cancer	0.000173	0.00236	CcSEcCtD
Theophylline—Decreased appetite—Etoposide—brain cancer	0.00017	0.00232	CcSEcCtD
Theophylline—CYP2E1—endocrine gland—brain cancer	0.000168	0.00291	CbGeAlD
Theophylline—Dizziness—Carmustine—brain cancer	0.000168	0.00228	CcSEcCtD
Theophylline—Diarrhoea—Temozolomide—brain cancer	0.000168	0.00228	CcSEcCtD
Theophylline—CYP1A1—central nervous system—brain cancer	0.000166	0.00288	CbGeAlD
Theophylline—CYP2E1—head—brain cancer	0.000166	0.00288	CbGeAlD
Theophylline—Dizziness—Temozolomide—brain cancer	0.000162	0.0022	CcSEcCtD
Theophylline—Vomiting—Carmustine—brain cancer	0.000161	0.00219	CcSEcCtD
Theophylline—Gastrointestinal pain—Etoposide—brain cancer	0.00016	0.00218	CcSEcCtD
Theophylline—Rash—Carmustine—brain cancer	0.00016	0.00217	CcSEcCtD
Theophylline—Dermatitis—Carmustine—brain cancer	0.00016	0.00217	CcSEcCtD
Theophylline—Headache—Carmustine—brain cancer	0.000159	0.00216	CcSEcCtD
Theophylline—Vomiting—Temozolomide—brain cancer	0.000156	0.00212	CcSEcCtD
Theophylline—Urticaria—Etoposide—brain cancer	0.000156	0.00212	CcSEcCtD
Theophylline—Abdominal pain—Etoposide—brain cancer	0.000155	0.00211	CcSEcCtD
Theophylline—Body temperature increased—Etoposide—brain cancer	0.000155	0.00211	CcSEcCtD
Theophylline—Rash—Temozolomide—brain cancer	0.000155	0.0021	CcSEcCtD
Theophylline—Dermatitis—Temozolomide—brain cancer	0.000154	0.0021	CcSEcCtD
Theophylline—Headache—Temozolomide—brain cancer	0.000154	0.00209	CcSEcCtD
Theophylline—CYP2E1—central nervous system—brain cancer	0.000152	0.00262	CbGeAlD
Theophylline—Nausea—Carmustine—brain cancer	0.000151	0.00205	CcSEcCtD
Theophylline—CYP2E1—cerebellum—brain cancer	0.000148	0.00257	CbGeAlD
Theophylline—Nausea—Temozolomide—brain cancer	0.000146	0.00198	CcSEcCtD
Theophylline—Hypersensitivity—Etoposide—brain cancer	0.000144	0.00196	CcSEcCtD
Theophylline—CYP2C8—brain—brain cancer	0.000143	0.00248	CbGeAlD
Theophylline—Pruritus—Etoposide—brain cancer	0.000139	0.00189	CcSEcCtD
Theophylline—CYP3A4—endocrine gland—brain cancer	0.000136	0.00234	CbGeAlD
Theophylline—Diarrhoea—Etoposide—brain cancer	0.000134	0.00182	CcSEcCtD
Theophylline—CYP2D6—endocrine gland—brain cancer	0.000133	0.00231	CbGeAlD
Theophylline—CYP1A1—brain—brain cancer	0.000132	0.00228	CbGeAlD
Theophylline—CYP2D6—head—brain cancer	0.000132	0.00228	CbGeAlD
Theophylline—Dizziness—Etoposide—brain cancer	0.00013	0.00176	CcSEcCtD
Theophylline—Vomiting—Etoposide—brain cancer	0.000125	0.0017	CcSEcCtD
Theophylline—Rash—Etoposide—brain cancer	0.000124	0.00168	CcSEcCtD
Theophylline—Dermatitis—Etoposide—brain cancer	0.000124	0.00168	CcSEcCtD
Theophylline—Headache—Etoposide—brain cancer	0.000123	0.00167	CcSEcCtD
Theophylline—CYP3A4—central nervous system—brain cancer	0.000122	0.00211	CbGeAlD
Theophylline—CYP2E1—brain—brain cancer	0.00012	0.00208	CbGeAlD
Theophylline—CYP2D6—central nervous system—brain cancer	0.00012	0.00208	CbGeAlD
Theophylline—CYP2D6—cerebellum—brain cancer	0.000117	0.00203	CbGeAlD
Theophylline—Nausea—Etoposide—brain cancer	0.000116	0.00158	CcSEcCtD
Theophylline—CYP2D6—brain—brain cancer	9.54e-05	0.00165	CbGeAlD
Theophylline—CYP2E1—Metabolism—CYP2C9—brain cancer	1.75e-05	0.000185	CbGpPWpGaD
Theophylline—ADA—Metabolism—PIK3CG—brain cancer	1.75e-05	0.000185	CbGpPWpGaD
Theophylline—HDAC2—Disease—HES1—brain cancer	1.75e-05	0.000185	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—PTCH1—brain cancer	1.74e-05	0.000184	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—SMO—brain cancer	1.74e-05	0.000184	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—HES1—brain cancer	1.74e-05	0.000183	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.73e-05	0.000183	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—VAV1—brain cancer	1.72e-05	0.000181	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—VAV1—brain cancer	1.7e-05	0.000179	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—HES1—brain cancer	1.68e-05	0.000178	CbGpPWpGaD
Theophylline—ADORA2B—GPCR downstream signaling—IL2—brain cancer	1.68e-05	0.000177	CbGpPWpGaD
Theophylline—PDE4C—Signaling by GPCR—IL2—brain cancer	1.67e-05	0.000177	CbGpPWpGaD
Theophylline—HDAC2—Disease—PDGFRA—brain cancer	1.67e-05	0.000176	CbGpPWpGaD
Theophylline—PDE3B—Hemostasis—TP53—brain cancer	1.66e-05	0.000175	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—HES1—brain cancer	1.66e-05	0.000175	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—PDGFRA—brain cancer	1.65e-05	0.000174	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—CYP2C9—brain cancer	1.65e-05	0.000174	CbGpPWpGaD
Theophylline—PDE3B—GPCR downstream signaling—IL2—brain cancer	1.63e-05	0.000172	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—SPP1—brain cancer	1.61e-05	0.000169	CbGpPWpGaD
Theophylline—PDE4D—GPCR downstream signaling—IL2—brain cancer	1.6e-05	0.000169	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—PDGFRA—brain cancer	1.6e-05	0.000169	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.6e-05	0.000169	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—VEGFA—brain cancer	1.6e-05	0.000169	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—IRS2—brain cancer	1.59e-05	0.000168	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—PDGFRA—brain cancer	1.58e-05	0.000166	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—HES1—brain cancer	1.58e-05	0.000166	CbGpPWpGaD
Theophylline—ADORA2A—GPCR downstream signaling—PIK3CG—brain cancer	1.57e-05	0.000166	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—SPP1—brain cancer	1.56e-05	0.000164	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—ENO2—brain cancer	1.55e-05	0.000164	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—HES1—brain cancer	1.53e-05	0.000162	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—SPP1—brain cancer	1.53e-05	0.000162	CbGpPWpGaD
Theophylline—ADORA2B—Signaling by GPCR—IL2—brain cancer	1.53e-05	0.000161	CbGpPWpGaD
Theophylline—PDE4A—GPCR downstream signaling—IL2—brain cancer	1.53e-05	0.000161	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—CYP2C9—brain cancer	1.52e-05	0.00016	CbGpPWpGaD
Theophylline—PDE3A—Hemostasis—TP53—brain cancer	1.51e-05	0.000159	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—PDGFRA—brain cancer	1.5e-05	0.000158	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—NOTCH2—brain cancer	1.5e-05	0.000158	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—BSG—brain cancer	1.49e-05	0.000157	CbGpPWpGaD
Theophylline—PDE3A—GPCR downstream signaling—IL2—brain cancer	1.49e-05	0.000157	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—IL2—brain cancer	1.48e-05	0.000156	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—HES1—brain cancer	1.48e-05	0.000156	CbGpPWpGaD
Theophylline—HDAC2—Disease—IRS2—brain cancer	1.46e-05	0.000154	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—PDGFRA—brain cancer	1.46e-05	0.000154	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—HES1—brain cancer	1.46e-05	0.000154	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—SPP1—brain cancer	1.46e-05	0.000154	CbGpPWpGaD
Theophylline—PDE4D—Signaling by GPCR—IL2—brain cancer	1.46e-05	0.000154	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—IRS2—brain cancer	1.45e-05	0.000153	CbGpPWpGaD
Theophylline—ADORA1—GPCR downstream signaling—IL2—brain cancer	1.43e-05	0.000151	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—VAV1—brain cancer	1.43e-05	0.00015	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—PIK3CG—brain cancer	1.42e-05	0.00015	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—SPP1—brain cancer	1.42e-05	0.00015	CbGpPWpGaD
Theophylline—PDE4B—GPCR downstream signaling—IL2—brain cancer	1.41e-05	0.000149	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—IRS2—brain cancer	1.41e-05	0.000149	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—PDGFRA—brain cancer	1.41e-05	0.000148	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—BSG—brain cancer	1.41e-05	0.000148	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—PIK3CG—brain cancer	1.41e-05	0.000148	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—APC—brain cancer	1.41e-05	0.000148	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—NOTCH2—brain cancer	1.39e-05	0.000147	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—PDGFRA—brain cancer	1.39e-05	0.000147	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—IL2—brain cancer	1.39e-05	0.000146	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—IRS2—brain cancer	1.38e-05	0.000146	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—SPP1—brain cancer	1.36e-05	0.000144	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—IL2—brain cancer	1.35e-05	0.000142	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—SPP1—brain cancer	1.35e-05	0.000142	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—VAV1—brain cancer	1.33e-05	0.00014	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—IRS2—brain cancer	1.32e-05	0.000139	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—IL2—brain cancer	1.3e-05	0.000137	CbGpPWpGaD
Theophylline—HDAC2—Disease—APC—brain cancer	1.29e-05	0.000136	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—BSG—brain cancer	1.29e-05	0.000136	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—IL2—brain cancer	1.28e-05	0.000135	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—IRS2—brain cancer	1.28e-05	0.000135	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—APC—brain cancer	1.28e-05	0.000135	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—PIK3CG—brain cancer	1.28e-05	0.000135	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—IDH1—brain cancer	1.28e-05	0.000135	CbGpPWpGaD
Theophylline—PDE4C—Signaling by GPCR—EGFR—brain cancer	1.28e-05	0.000135	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CYP2C9—brain cancer	1.24e-05	0.000131	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—APC—brain cancer	1.24e-05	0.000131	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—PIK3CG—brain cancer	1.24e-05	0.000131	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—IRS2—brain cancer	1.23e-05	0.00013	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—HES1—brain cancer	1.23e-05	0.000129	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—APC—brain cancer	1.22e-05	0.000129	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—PIK3CG—brain cancer	1.22e-05	0.000129	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—IRS2—brain cancer	1.22e-05	0.000129	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—IDH1—brain cancer	1.21e-05	0.000127	CbGpPWpGaD
Theophylline—HDAC2—Hemostasis—TP53—brain cancer	1.21e-05	0.000127	CbGpPWpGaD
Theophylline—ADORA2B—Signaling by GPCR—EGFR—brain cancer	1.17e-05	0.000123	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—PDGFRA—brain cancer	1.17e-05	0.000123	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—APC—brain cancer	1.16e-05	0.000123	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—PIK3CG—brain cancer	1.16e-05	0.000123	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—HES1—brain cancer	1.14e-05	0.00012	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—SPP1—brain cancer	1.13e-05	0.00012	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—EGFR—brain cancer	1.13e-05	0.00012	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—APC—brain cancer	1.13e-05	0.000119	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—PIK3CG—brain cancer	1.13e-05	0.000119	CbGpPWpGaD
Theophylline—PDE4D—Signaling by GPCR—EGFR—brain cancer	1.11e-05	0.000118	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—IDH1—brain cancer	1.11e-05	0.000117	CbGpPWpGaD
Theophylline—ADORA2A—GPCR downstream signaling—IL2—brain cancer	1.1e-05	0.000117	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—RELA—brain cancer	1.1e-05	0.000116	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—ERBB2—brain cancer	1.09e-05	0.000115	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—APC—brain cancer	1.09e-05	0.000115	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—PIK3CG—brain cancer	1.09e-05	0.000115	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—PDGFRA—brain cancer	1.09e-05	0.000115	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—APC—brain cancer	1.08e-05	0.000114	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—PIK3CG—brain cancer	1.08e-05	0.000114	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—EGFR—brain cancer	1.06e-05	0.000112	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—BSG—brain cancer	1.06e-05	0.000112	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—SPP1—brain cancer	1.05e-05	0.000111	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CYP2C9—brain cancer	1.05e-05	0.000111	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—BSG—brain cancer	1.05e-05	0.000111	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—EGFR—brain cancer	1.03e-05	0.000109	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—IRS2—brain cancer	1.03e-05	0.000108	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—ENO2—brain cancer	1.01e-05	0.000107	CbGpPWpGaD
Theophylline—HDAC2—Disease—ERBB2—brain cancer	1e-05	0.000106	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—IL2—brain cancer	1e-05	0.000106	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—RELA—brain cancer	1e-05	0.000106	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—ERBB2—brain cancer	9.96e-06	0.000105	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—EGFR—brain cancer	9.93e-06	0.000105	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—IL2—brain cancer	9.89e-06	0.000104	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.84e-06	0.000104	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—EGFR—brain cancer	9.81e-06	0.000104	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—RELA—brain cancer	9.72e-06	0.000103	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—ERBB2—brain cancer	9.66e-06	0.000102	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—CCND1—brain cancer	9.64e-06	0.000102	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—RELA—brain cancer	9.56e-06	0.000101	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—ENO2—brain cancer	9.55e-06	0.000101	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—CTNNB1—brain cancer	9.55e-06	0.000101	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—IRS2—brain cancer	9.53e-06	0.000101	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—ERBB2—brain cancer	9.5e-06	0.0001	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—RELA—brain cancer	9.1e-06	9.6e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—IDH1—brain cancer	9.09e-06	9.6e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—PIK3CG—brain cancer	9.05e-06	9.55e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—APC—brain cancer	9.05e-06	9.55e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—ERBB2—brain cancer	9.04e-06	9.54e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—IL2—brain cancer	9.02e-06	9.52e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.02e-06	9.52e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—IDH1—brain cancer	9.02e-06	9.51e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—BSG—brain cancer	8.96e-06	9.45e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—RELA—brain cancer	8.85e-06	9.34e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—CCND1—brain cancer	8.8e-06	9.28e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—ERBB2—brain cancer	8.79e-06	9.28e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—CTNNB1—brain cancer	8.78e-06	9.27e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—ENO2—brain cancer	8.76e-06	9.24e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—IL2—brain cancer	8.75e-06	9.23e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—CTNNB1—brain cancer	8.71e-06	9.19e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—IL2—brain cancer	8.61e-06	9.08e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—CCND1—brain cancer	8.53e-06	9e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—RELA—brain cancer	8.52e-06	8.99e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—ERBB2—brain cancer	8.47e-06	8.93e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—CTNNB1—brain cancer	8.45e-06	8.91e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—RELA—brain cancer	8.42e-06	8.88e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—PIK3CG—brain cancer	8.42e-06	8.88e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—APC—brain cancer	8.42e-06	8.88e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—VEGFA—brain cancer	8.4e-06	8.87e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—CCND1—brain cancer	8.39e-06	8.85e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—ERBB2—brain cancer	8.36e-06	8.83e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—STAT3—brain cancer	8.32e-06	8.78e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—CTNNB1—brain cancer	8.31e-06	8.77e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—IL2—brain cancer	8.19e-06	8.64e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYP2C9—brain cancer	8.13e-06	8.58e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—CCND1—brain cancer	7.99e-06	8.43e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—IL2—brain cancer	7.97e-06	8.41e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—CTNNB1—brain cancer	7.91e-06	8.34e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—CCND1—brain cancer	7.77e-06	8.2e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—MYC—brain cancer	7.73e-06	8.16e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—IDH1—brain cancer	7.7e-06	8.13e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—CTNNB1—brain cancer	7.69e-06	8.12e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—IL2—brain cancer	7.67e-06	8.09e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—EGFR—brain cancer	7.67e-06	8.09e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—VEGFA—brain cancer	7.67e-06	8.09e-05	CbGpPWpGaD
Theophylline—HDAC2—Gene Expression—MYC—brain cancer	7.66e-06	8.08e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—STAT3—brain cancer	7.66e-06	8.08e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—STAT3—brain cancer	7.59e-06	8.01e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—IL2—brain cancer	7.58e-06	8e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—EGFR—brain cancer	7.56e-06	7.98e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—CCND1—brain cancer	7.48e-06	7.89e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—VEGFA—brain cancer	7.44e-06	7.85e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—CTNNB1—brain cancer	7.41e-06	7.81e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—CCND1—brain cancer	7.39e-06	7.8e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—STAT3—brain cancer	7.36e-06	7.77e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.34e-06	7.75e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—CTNNB1—brain cancer	7.32e-06	7.72e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—VEGFA—brain cancer	7.32e-06	7.72e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—STAT3—brain cancer	7.24e-06	7.64e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ENO2—brain cancer	7.19e-06	7.59e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ENO2—brain cancer	7.13e-06	7.52e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PIK3CG—brain cancer	7.12e-06	7.51e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—MYC—brain cancer	7.11e-06	7.51e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—RELA—brain cancer	7.07e-06	7.46e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—MYC—brain cancer	7.06e-06	7.44e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—ERBB2—brain cancer	7.03e-06	7.42e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—VEGFA—brain cancer	6.96e-06	7.35e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—EGFR—brain cancer	6.96e-06	7.34e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—BSG—brain cancer	6.91e-06	7.3e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—EGFR—brain cancer	6.9e-06	7.28e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—STAT3—brain cancer	6.89e-06	7.27e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—MYC—brain cancer	6.84e-06	7.22e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—VEGFA—brain cancer	6.77e-06	7.15e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—MYC—brain cancer	6.73e-06	7.1e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—STAT3—brain cancer	6.71e-06	7.08e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—EGFR—brain cancer	6.69e-06	7.06e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—EGFR—brain cancer	6.58e-06	6.95e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—RELA—brain cancer	6.58e-06	6.94e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—ERBB2—brain cancer	6.54e-06	6.9e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—VEGFA—brain cancer	6.52e-06	6.88e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—STAT3—brain cancer	6.46e-06	6.81e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—VEGFA—brain cancer	6.44e-06	6.8e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—MYC—brain cancer	6.41e-06	6.76e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—STAT3—brain cancer	6.38e-06	6.73e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—IL2—brain cancer	6.37e-06	6.72e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—TP53—brain cancer	6.35e-06	6.7e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.27e-06	6.62e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—EGFR—brain cancer	6.27e-06	6.61e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—MYC—brain cancer	6.23e-06	6.58e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CCND1—brain cancer	6.21e-06	6.55e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CTNNB1—brain cancer	6.15e-06	6.49e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—EGFR—brain cancer	6.1e-06	6.43e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ENO2—brain cancer	6.09e-06	6.43e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—MYC—brain cancer	6e-06	6.33e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—IDH1—brain cancer	5.95e-06	6.27e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—MYC—brain cancer	5.93e-06	6.25e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—IL2—brain cancer	5.92e-06	6.25e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—EGFR—brain cancer	5.87e-06	6.19e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—EGFR—brain cancer	5.8e-06	6.12e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—TP53—brain cancer	5.79e-06	6.11e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CCND1—brain cancer	5.77e-06	6.09e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CTNNB1—brain cancer	5.72e-06	6.03e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—TP53—brain cancer	5.62e-06	5.93e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—TP53—brain cancer	5.53e-06	5.83e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—VEGFA—brain cancer	5.42e-06	5.71e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—STAT3—brain cancer	5.36e-06	5.66e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—TP53—brain cancer	5.26e-06	5.55e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—TP53—brain cancer	5.12e-06	5.4e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—VEGFA—brain cancer	5.03e-06	5.31e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—STAT3—brain cancer	4.98e-06	5.26e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MYC—brain cancer	4.98e-06	5.26e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—TP53—brain cancer	4.93e-06	5.2e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—EGFR—brain cancer	4.87e-06	5.14e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—TP53—brain cancer	4.87e-06	5.14e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ENO2—brain cancer	4.7e-06	4.96e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CG—brain cancer	4.65e-06	4.9e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MYC—brain cancer	4.63e-06	4.89e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—EGFR—brain cancer	4.53e-06	4.78e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CG—brain cancer	4.38e-06	4.62e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TP53—brain cancer	4.09e-06	4.32e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CG—brain cancer	4.02e-06	4.24e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TP53—brain cancer	3.8e-06	4.01e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CG—brain cancer	3.3e-06	3.48e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CG—brain cancer	3.27e-06	3.45e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CG—brain cancer	2.79e-06	2.95e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CG—brain cancer	2.16e-06	2.27e-05	CbGpPWpGaD
